[Therapy of acute cerebrovascular insufficiency].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001929:Brain Edema / Q000188:drug therapy; D002543:Cerebral Hemorrhage / Q000150:complications; D002544:Cerebral Infarction / Q000150:complications; D002561:Cerebrovascular Disorders / Q000378:metabolism / Q000628:therapy*; D004232:Diuretics / Q000627:therapeutic use; D004573:Electrolytes / Q000627:therapeutic use; D005632:Fructose / Q000627:therapeutic use; D006801:Humans; D011014:Pneumonia / Q000517:prevention & control; D011195:Potassium Magnesium Aspartate / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000009:adverse effects; D014882:Water-Electrolyte Balance
D000900:Anti-Bacterial Agents; D004232:Diuretics; D004573:Electrolytes; D014665:Vasodilator Agents; D005632:Fructose; D011195:Potassium Magnesium Aspartate
Zur Therapie der Akuten zerebrovaskulären Insuffizienz.